Wnt signalling is involved in the initiation and progression of breast cancer by Wnt proteins combining with low-density-lipoprotein receptor-related proteins 5/6 (LRP5/6) and receptors Frizzled (FZD), and initiating β-catenin-dependent or -independent signalling pathways46. This evidence concerns the gene LRP5 and breast carcinoma.